COVID-19, COVID-19 Acute Respiratory Distress Syndrome
Conditions
Brief summary
The investigators retrospectively investigate the epidemiology, clinical characteristics and therapeutic interventions of patients with COVID-19 associated respiratory failure admitted to the intensive care units in South Tyrol, Italy.
Detailed description
In this observational, retrospective study the epidemiology, characteristics, therapeutic interventions and outcome of patients with COVID-19 associated respiratory failure admitted to the intensive care units in South Tyrol, Italy, are assessed. Data extracted from the medical patients' records include type and duration of respiratory support (high-flow nasal oxygen, non-invasive ventilation, invasive ventilation), need for tracheostomy, vasopressor needs, antibiotic therapy, corticosteroid treatment, laboratory values (interleukin-6, C-reactive protein, procalcitonin, D-dimer, lymphocyte count), lengths of stay in the ICU and mortality.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients admitted to the intensive care units in South Tyrol due to COVID-19 associated respiratory failure
Exclusion criteria
* SARS-CoV-2 patients admitted to the intensive care units in South Tyrol for other pathologies (i.e., not respiratory failure)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | Through study completion, an average of 1 year | Mortality (dead/alive) at discharge from the ICU is defined as primary outcome |
Countries
Italy